Title:
FUSED RING COMPOUNDS AS INHIBITORS OF FGFR4 TYROSINE KINASES
Document Type and Number:
WIPO Patent Application WO/2023/039828
Kind Code:
A1
Abstract:
Relates to fused ring compounds, and pharmaceutical compositions including the same, inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases, especially FGFR4-associated diseases, such as cancer.
Inventors:
ZHANG JIAN (CN)
ZHOU JINCONG (CN)
ZHANG SHAOMIN (CN)
CAI HUIHUA (CN)
HE KANG (CN)
WU JIAJIA (CN)
ZHOU JINCONG (CN)
ZHANG SHAOMIN (CN)
CAI HUIHUA (CN)
HE KANG (CN)
WU JIAJIA (CN)
Application Number:
PCT/CN2021/119035
Publication Date:
March 23, 2023
Filing Date:
September 17, 2021
Export Citation:
Assignee:
NUTSHELL BIOTECH SHANGHAI CO LTD (CN)
International Classes:
C07D471/00; A61K31/519; A61P35/00
Foreign References:
| CN105307657A | 2016-02-03 | |||
| US20160115164A1 | 2016-04-28 | |||
| CN105263931A | 2016-01-20 |
Attorney, Agent or Firm:
NTD UNIVATION INTELLECTUAL PROPERTY AGENCY LTD. (CN)
Download PDF: